FX & CFD trading involves significant risk
U.S. stocks fell earlier after the Commerce Department said U.S. gross domestic product expanded at a 2 percent rate in the third quarter, slower than previously reported. The S&P 500 rebounded after the IMF announced changes to the credit line, enabling countries the pre-qualify to request IMF funds without having to make as many policy changes.
Published today, macroeconomic statistics was of a negative nature - according to revised data, GDP in the third quarter increased by 2% instead of 2.5% mentioned in the preliminary assessment. A day earlier, the committee members of the U.S. Congress failed to agree on measures to reduce the budget deficit of the country, and the resolution of this issue may be very prolonged. Nevertheless, the news that the major rating agencies affirmed the credit rating of the United States, limited the bearish on the market. In particular, the agency S & P affirms rating at AA +, Moody's - at AAA with a negative outlook. Fitch Ratings noted that the failure of "supercommittee" to cope with the task of developing measures to reduce the budget deficit could lead to a lowering of the forecast credit rating or even the ranking. The external background for the U.S. session today mostly negative - Asian indices showed mixed dynamics, and Europe were closed in the red.
Chevron Corp. and Kraft Foods Inc. added more than 1 percent, leading gains in the Dow Jones Industrial Average.
Hewlett-Packard Co. (HPQ) had the biggest retreat in the Dow Jones Industrial Average, slumping 3.3 percent. The largest computer maker gave a first-quarter profit forecast and full-year earnings outlook that missed analysts’ estimates.
Netflix video rental operator has lost 2.5% on the news about the placement of shares and convertible bonds worth $ 400 million
Gilead Sciences Inc. rose the most in the S&P 500, climbing 5.5 percent. The world’s largest maker of HIV medicines was boosted to “outperform” from “Market Perform” at BMO Capital Markets, which said the company’s acquisition of Pharmasset Inc.
Medtronic Inc. climbed 3.5 percent for the second-biggest gain in the S&P 500. The world’s biggest maker of heart-rhythm devices reported second-quarter earnings that beat analysts’ expectations on rising international sales of cardiovascular and spinal products.
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.